Burrill & Co. swells its life sciences fund to $505M

Amidst a tepid venture capital environment in the world of biotechnology, one VC firm has restocked its war chest to the tune of $505 million. San Francisco's Burrill & Co. closed its latest fund and looks to invest in healthcare and life sciences firms, including makers of devices, diagnostics and therapeutics. Report

Suggested Articles

Medtronic has moved to acquire Avenu Medical, developers of a minimally invasive method of building the blood vessel access ports.

The agency also gave the company’s diagnostic, run on the high-throughput Panther Fusion laboratory platform, a green light for pooled testing.

Smith & Nephew has signed up to acquire Integra LifeSciences’ orthopedics business focused on the growing upper and lower extremity markets.